drugset
drugset / Trial / NCT03760185

Pupil Dilation for Treatment of IFIS

NCT03760185 ↗

Phase 2 Completed 13 enrolled Denver Health and Hospital Authority
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.

Timeline

Start
2019-01-04
Primary completion
2020-09-25
Completion
2020-09-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 0.2 % Topical

Indications

intraoperative floppy iris syndrome